NCT00233610View on ClinicalTrials.gov

Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

Prostate Cancer

Interventions

DRUG

Bicalutamide

DRUG

Tamoxifen

Trial Locations (11)

Unknown

Research Site, Bari

Research Site, Bologna

Research Site, Catania

Research Site, Bagno a Ripoli

Research Site, Florence

Research Site, Genova

Research Site, Pisa

Research Site, Parma

Research Site, Roma

Research Site, Udine

Research Site, Como

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY